Definitive Healthcare Future Growth
Future criteria checks 4/6
Definitive Healthcare's revenue is forecast to decline at 0.7% per annum while its annual earnings are expected to grow at 127.7% per year. EPS is expected to grow by 125.3% per annum. Return on equity is forecast to be 31.4% in 3 years.
Key information
127.7%
Earnings growth rate
125.30%
EPS growth rate
| Healthcare Services earnings growth | 23.1% |
| Revenue growth rate | -0.7% |
| Future return on equity | 31.36% |
| Analyst coverage | Good |
| Last updated | 19 May 2025 |
Recent future growth updates
Recent updates
Improved Data Integration And Healthcare Partnerships Will Create Value
Enhancing data integration and customer retention efforts is expected to boost customer relationships, stabilize churn rates, and positively impact revenue and margins.Definitive Healthcare Corp.'s (NASDAQ:DH) Shares Climb 27% But Its Business Is Yet to Catch Up
Feb 11
A Dive Into Definitive Healthcare
Feb 04Is Definitive Healthcare (NASDAQ:DH) Weighed On By Its Debt Load?
Jan 14Definitive Healthcare: Poor Near-Term Outlook, But New CEO May Change Things
Aug 19More Unpleasant Surprises Could Be In Store For Definitive Healthcare Corp.'s (NASDAQ:DH) Shares After Tumbling 28%
Aug 01Definitive Healthcare: Weak Near-Term Growth To Put Valuation In Rangebound
Jun 25Risks Still Elevated At These Prices As Definitive Healthcare Corp. (NASDAQ:DH) Shares Dive 26%
May 30Pinning Down Definitive Healthcare Corp.'s (NASDAQ:DH) P/S Is Difficult Right Now
Apr 14Definitive Healthcare: Reiterate Buy Rating As I Expect Growth To Recover In FY25
Mar 19Is Definitive Healthcare (NASDAQ:DH) Using Debt In A Risky Way?
Feb 16An Intrinsic Calculation For Definitive Healthcare Corp. (NASDAQ:DH) Suggests It's 42% Undervalued
Dec 29Definitive Healthcare Corp. (NASDAQ:DH) Stock Rockets 31% As Investors Are Less Pessimistic Than Expected
Nov 24Estimating The Fair Value Of Definitive Healthcare Corp. (NASDAQ:DH)
Jun 02Definitive Healthcare Corp. (NASDAQ:DH) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
May 06A Look At The Fair Value Of Definitive Healthcare Corp. (NASDAQ:DH)
Dec 08Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2027 | 244 | 182 | 117 | 120 | 4 |
| 12/31/2026 | 241 | 12 | 73 | 71 | 13 |
| 12/31/2025 | 237 | -131 | 12 | 15 | 13 |
| 3/31/2025 | 248 | -511 | 48 | 68 | N/A |
| 12/31/2024 | 252 | -413 | 46 | 58 | N/A |
| 9/30/2024 | 256 | -364 | 53 | 55 | N/A |
| 6/30/2024 | 258 | -405 | 43 | 45 | N/A |
| 3/31/2024 | 256 | -200 | 41 | 43 | N/A |
| 12/31/2023 | 251 | -202 | 38 | 41 | N/A |
| 9/30/2023 | 246 | -182 | 25 | 32 | N/A |
| 6/30/2023 | 238 | -14 | 25 | 33 | N/A |
| 3/31/2023 | 232 | -11 | 28 | 37 | N/A |
| 12/31/2022 | 223 | -7 | 27 | 36 | N/A |
| 9/30/2022 | 208 | -27 | 39 | 44 | N/A |
| 6/30/2022 | 194 | -32 | 29 | 32 | N/A |
| 3/31/2022 | 179 | -16 | 22 | 25 | N/A |
| 12/31/2021 | 166 | -18 | 18 | 25 | N/A |
| 9/30/2021 | 153 | -8 | 24 | 30 | N/A |
| 6/30/2021 | 140 | N/A | 26 | 31 | N/A |
| 3/31/2021 | 128 | 2 | 25 | 30 | N/A |
| 12/31/2020 | 118 | N/A | 22 | 23 | N/A |
| 12/31/2019 | 86 | -36 | 20 | 22 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: DH is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.9%).
Earnings vs Market: DH is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: DH is expected to become profitable in the next 3 years.
Revenue vs Market: DH's revenue is expected to decline over the next 3 years (-0.7% per year).
High Growth Revenue: DH's revenue is forecast to decline over the next 3 years (-0.7% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: DH's Return on Equity is forecast to be high in 3 years time (31.4%)
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/28 22:41 |
| End of Day Share Price | 2025/05/28 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Definitive Healthcare Corp. is covered by 18 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Joseph Vruwink | Baird |
| Saket Kalia | Barclays |
| Allen Lutz | BofA Global Research |